

Can't find or afford Orilissa? Here are real alternatives for endometriosis pain, including other GnRH treatments and hormonal therapies your doctor may consider.
Orilissa (Elagolix) was a breakthrough when it was approved in 2018 — the first oral GnRH antagonist for endometriosis pain. But in 2026, many patients still struggle to access it. Whether the issue is availability at your pharmacy, insurance denials, or a price tag that can reach $1,700 per month, you may be wondering: what else is out there?
The good news is that several effective alternatives exist. In this article, we'll explain how Orilissa works and walk through the most common alternatives your doctor may consider.
Orilissa is a GnRH (gonadotropin-releasing hormone) antagonist made by AbbVie. Its active ingredient, Elagolix, blocks the GnRH receptor in the pituitary gland. This suppresses the production of estrogen and progesterone — the hormones that fuel endometrial tissue growth outside the uterus.
By lowering estrogen levels, Orilissa reduces the inflammation and pain caused by endometriosis. It's available in two doses:
Understanding this mechanism is important because it helps explain why certain alternatives may work for you — and why others work differently.
Lupron Depot is a GnRH agonist — which is different from Orilissa's GnRH antagonist mechanism, but achieves a similar end result. After an initial hormone surge (called a "flare"), Lupron Depot suppresses estrogen production, effectively putting the body into a temporary menopausal state.
Key facts about Lupron Depot:
Lupron Depot is often used with "add-back" therapy (low-dose Norethindrone) to reduce side effects like hot flashes and bone loss.
Myfembree is a newer oral option that combines a GnRH antagonist (Relugolix) with add-back hormones (estradiol and norethindrone acetate) in a single pill. It was originally approved for uterine fibroids and has been studied for endometriosis.
Key facts about Myfembree:
If you like the idea of an oral GnRH antagonist (like Orilissa) but want built-in protection against bone loss, Myfembree may be worth discussing with your doctor.
Norethindrone acetate is a progestin (synthetic progesterone) that is used off-label for endometriosis pain. It works by suppressing ovulation and thinning the endometrial lining, which can reduce pain.
Key facts about Norethindrone acetate:
For patients who can't access or afford Orilissa, Norethindrone is often the first alternative doctors consider because of its low cost and availability.
Depo-Provera is an injectable progestin given every 3 months. Like Norethindrone, it works by suppressing ovulation and reducing endometrial growth.
Key facts about Depo-Provera:
The best alternative depends on your specific situation, including:
Talk to your OB/GYN or reproductive endocrinologist about which option makes the most sense for you. They can weigh the pros and cons based on your medical history.
Orilissa is a powerful tool for managing endometriosis pain, but it's not the only option. Whether you're dealing with availability issues, insurance roadblocks, or cost concerns, there are real alternatives that can help.
If you'd still like to try to find Orilissa, use Medfinder to search for pharmacies that have it in stock, or read our article on how to find Orilissa near you. And if cost is the main barrier, check out how to save money on Orilissa in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.